BA.1 OMICRON VARIANT

China's CanSino reports 'positive' interim data from COVID mRNA booster trial

The 433-person trial of those aged 18 and above tested a booster shot of the vaccine, called CS-2034, in people who had already received three doses of an inactivated vaccine, the drugmaker said in a filing to the Hong Kong stock exchange.